natgillin/translations-raw huggingface dataset:
If a patient wishes to become pregnant, treatment with Competact should be discontinued.
Če želi bolnica zanositi, je treba zdravljenje z zdravilom Competact prekiniti.
Fluid retention and cardiac failure
Zastajanje tekočine in srčno popuščanje).
Broken bones have been reported commonly (may affect up to 1 in 10 people) in female patients taking Competact and have also been reported in male patients (frequency cannot be estimated from the available data) taking Competact.
O zlomih so poročali tudi pri bolnikih, ki so se zdravili z zdravilom Competact (pogostnosti ni mogoče oceniti iz razpoložljivih podatkov).
Bladder cancer has been experienced uncommonly (may affect up to 1 in 100 people) in patients taking Competact.
Pri bolnikih, ki so jemali zdravilo Competact, so občasno (pri največ 1 od 100 bolnikov) poročali o pojavu raka sečnega mehurja.
- by reduction of hepatic glucose production by inhibiting gluconeogenesis and glycogenolysis - in muscle, by modestly increasing insulin sensitivity, improving peripheral glucose uptake and utilisation - by delaying intestinal glucose absorption.
- v mišicah zmerno poveča občutljivost za insulin, izboljša periferni vnos in izkoriščanje glukoze;
Symptoms of lactic acidosis include: - vomiting - stomach ache (abdominal pain) - muscle cramps - a general feeling of not being well with severe tiredness - difficulty in breathing - reduced body temperature and heartbeat
- bolečina v trebuhu (abdominalna bolečina) - mišične krče - splošno slabo počutje s hudo utrujenostjo
Adverse reactions reported in double-blind studies and post-marketing experience are listed below as MedDRA preferred term by system organ class and absolute frequency.
Neželeni učinki, o katerih so poročali v dvojno slepih študijah in postmarketinških izkušnjah, so našteti spodaj, in sicer po razredih organskih sistemov in absolutni pogostnosti, kot je priporočeno po MedDRA. Pogostnosti so določene kot: zelo pogosti (≥ 1/10); pogosti (≥ 1/100 do < 1/10); občasni
- a significant reduction of the absolute risk of any diabetes-related complication in the metformin group (29.8 events/1,000 patient-years) versus diet alone (43.3 events/1,000 patient-years), p=0.0023, and versus the combined sulphonylurea and insulin monotherapy groups (40.1 events/1,000 patient-years), p=0.0034 - a significant reduction of the absolute risk of any diabetes-related mortality: metformin 7.5 events/1,000 patient-years, diet alone 12.7 events/1,000 patient-years, p=0.017 - a significant reduction of the absolute risk of overall mortality: metformin 13.5 events/1,000 patient-years versus diet alone 20.6 events/1,000 patient-years, (p=0.011), and versus the combined sulphonylurea and insulin monotherapy groups 18.9 events/1,000 patient-years (p=0.021)
značilno zmanjšanje absolutnega tveganja za katerikoli s sladkorno boleznijo povezan zaplet v skupini bolnikov, ki so se zdravili z metforminom (29,8 primerov/1.000 bolnikov-let), v primerjavi s skupino bolnikov, ki je imela predpisano zgolj dieto (43,3 primerov/1.000 bolnikov-let), p = 0,0023 ter v primerjavi s skupino, ki se je kombinirano zdravila s sulfonilsečnino, in skupino, ki je imela monoterapijo z insulinom
It is especially important to mention the following: - gemfibrozil (used to lower cholesterol) - rifampicin (used to treat tuberculosis and other infections) - cimetidine (used to reduce stomach acid) - glucocorticoids (used to treat inflammation) - beta-2-agonists (used to treat asthma) - medicines which increase urine production (diuretics) - medicines used to treat pain and inflammation (NSAID and COX-2-inhibitors, such as ibuprofen and celecoxib) - certain medicines for the treatment of high blood pressure (angiotensin-converting enzyme
Posebno pomembno je omeniti naslednje: - gemfibrozil (uporablja se za zniževanje holesterola) - rifampicin (uporablja se za zdravljenje tuberkuloze in drugih okužb)
Food had no effect on the AUC and Cmax of pioglitazone when Competact was administered to healthy volunteers.
Pri zdravih prostovoljcih, ki so dobivali zdravilo Competact hrana ni vplivala na AUC in Cmax pioglitazona.
Maximum daily dose is 1,000 mg.
30 do 44 Največji dnevni odmerek je 1.000 mg.
Common (may affect up to 1 in 10 people) - localised swelling (oedema) - weight gain - headache - respiratory infection - abnormal vision - joint pain - impotence - blood in urine - reduction in blood count (anaemia) - numbness - taste disturbance
- impotenca - kri v urinu - zmanjšanje števila krvnih celic (anemija) - odrevenelost - motnje čuta za okušanje
- Acute conditions with the potential to alter renal function such as: Dehydration Severe infection Shock - Intravascular administration of iodinated contrast agents (see section 4.4) - Breast-feeding (see section 4.6)
- intravenski uporabi jodiranih kontrastnih sredstev (glejte poglavje 4.4); - dojenju (glejte poglavje 4.6).
How to store Competact
Shranjevanje zdravila Competact
Competact 15 mg/850 mg tablets pioglitazone/metformin hydrochloride
Competact 15 mg/850 mg tablete pioglitazon/metforminijev klorid
Combinations requiring precautions for use
NAVODILA ZA UPORABO
Therapy with Competact should not be initiated in patients with increased baseline liver enzyme levels (ALT > 2.5 x upper limit of normal) or with any other evidence of liver disease.
(ALT > 2,5-kratna zgornja meja normalnih vrednosti) ali s kakršnimi koli drugimi znaki jetrne bolezni, zdravljenja z zdravilom Competact ne smemo začeti.
Very rare (may affect up to 1 in 10,000) - decrease in amount of vitamin B12 in the blood - redness of the skin - itchy skin - raised and itchy rash (hives)
Zelo redki (pojavi se lahko pri do 1 od 10.000 bolnikov) - znižanje vrednosti vitamina B12 v krvi
- a significant reduction in the absolute risk of myocardial infarction: metformin 11 events/1,000 patient-years, diet alone 18 events/1,000 patient-years, (p=0.01).
metformin-11 primerov/1.000 bolnikov-let, dieta sama-18 primerov/1.000 bolnikov-let (p = 0,01).
If you stop using Competact, your blood sugar may go up.
Če zdravilo Competact prenehate jemati, se lahko raven krvnega sladkorja zviša, zato se pred prekinitvijo zdravljenja najprej posvetujte z zdravnikom.
Competact should be discontinued if any deterioration in cardiac status occurs.
Če se pojavi kakršnokoli poslabšanje srčnega statusa, je treba zdravljenje z zdravilom Competact ukiniti.
Maximum daily dose is 3,000 mg.
60 do 89 Največji dnevni odmerek je 3.000 mg.
Not known (frequency can not be estimated from the available data) - inflammation of the liver (hepatitis) - liver does not work as well as it should (changes in liver enzymes)
- vnetje jeter (hepatitis) - motnje v delovanju jeter (sprememba vrednosti jetrnih encimov)
Some medicinal products that can adversely affect renal function which may increase the risk of lactic acidosis, e.g. NSAIDS, including selective cyclo-oxygenase (COX) II inhibitors, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists and diuretics, especially loop diuretics.
Kombinacije, pri katerih so potrebni previdnostni ukrepi Nekatera zdravila lahko škodljivo vplivajo na delovanje ledvic, kar lahko poveča tveganje za laktacidozo, npr. nesteroidna protivnetna zdravila, vključno s selektivnimi zaviralci ciklooksigenaze
Taking into account the PRAC Assessment Report on the PSUR(s) for glimepiride / pioglitazone hydrochloride, metformin / pioglitazone, pioglitazone, the scientific conclusions of CHMP are as follows:
Upoštevajoč poročilo Odbora za oceno tveganja na področju farmakovigilance (PRAC) o oceni rednih posodobljenih poročil o varnosti zdravila (PSUR) za glimepirid/pioglitazon hidroklorid,
Uncommon (may affect up to 1 in 100 people) - inflammation of the sinuses (sinusitis) - gas - difficulty sleeping (insomnia)
- vnetje sinusov (sinuzitis) - vetrovi - težave s spanjem (nespečnost)
Competact 15 mg/850 mg film-coated tablets pioglitazone/metformin hydrochloride
Competact 15 mg/850 mg filmsko obložene tablete pioglitazon/metforminijev klorid
Inform your doctor as soon as possible if you develop symptoms suggesting a problem with your liver (like feeling sick without explanations, vomiting, stomach ache, tiredness, loss of appetite and/or dark urine) as your liver function should be checked.
(kot je občutek slabosti brez razloga, bruhanje, bolečine v trebuhu, utrujenost, izguba apetita in/ali temen urin), ker je potrebno preveriti delovanje jeter.
- Hypersensitivity to the active substances or to any of the excipients listed in section 6.1 - Cardiac failure or history of cardiac failure (NYHA stages I to IV) - Current bladder cancer or a history of bladder cancer - Uninvestigated macroscopic haematuria - Acute or chronic disease which may cause tissue hypoxia such as cardiac or respiratory failure,
- akutnih ali kroničnih boleznih, ki so lahko vzrok hipoksije tkiv, npr. srčno ali respiratorno popuščanje, nedaven miokardni infarkt, šok;
(ACE) inhibitors and angiotensin II receptor antagonists)
(COX) II, zaviralci angiotenzinske konvertaze (zaviralci ACE), antagonisti receptorjev angiotenzina II in diuretiki, zlasti diuretiki Henlejeve zanke.
14 Tablet blister
filmsko obložena tableta 14 tablet
Posology
Sre
Maximum daily dose is 2,000 mg.
45 do 59 Največji dnevni odmerek je 2.000 mg.
Package leaflet: Information for the patient Competact 15 mg/850 mg film-coated tablets pioglitazone/metformin hydrochloride
Navodilo za uporabo Competact 15 mg/850 mg filmsko obložene tablete pioglitazon/metforminijev klorid
Others
Sob
Pioglitazone should be used with caution during concomitant administration of cytochrome P450 2C8 inhibitors (e.g. gemfibrozil) or inducers (e.g. rifampicin).
Pri sočasnem dajanju z zaviralci (npr. gemfibrozil) ali induktorji (npr. rifampicin) citokroma P450 2C8
recent myocardial infarction, shock - Hepatic impairment - Acute alcohol intoxication, alcoholism - Any type of acute metabolic acidosis (such as lactic acidosis, diabetic ketoacidosis) - Diabetic pre-coma - Severe renal failure (GFR < 30 mL/min)
- huda ledvična odpoved (GFR < 30 ml/min); - akutnih stanjih, ki lahko spremenijo delovanje ledvic: dehidraciji; hudih okužbah; šoku;
Thu.
Pon
OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF BELANETTE AND ASSOCIATED NAMES (see Annex I)
ZAKLJUČNI POVZETEK ZNANSTVENEGA VREDNOTENJA ZDRAVILA BELANETTE IN POVEZANIH IMEN (glejte Dodatek I)
The valid Summary of Product Characteristics, labelling and package leaflet are the final versions achieved during the Coordination group procedure.
Veljavni povzetek glavnih značilnosti zdravila, ovojnina in navodilo za uporabo so končne verzije besedil, sprejete med postopkom Koordinacijske skupine..
Therefore blind users will be able to double check the information written on the cardboard wallets (Braille text) with the information obtained from a physician (during the visit).
Zato bodo slepi uporabniki lahko dodatno primerjali podatke, ki so zapisani na zloženkah iz lepenke (Braillova pisava) s podatki, ki so jih dobili od zdravnika (med obiskom).
ANNEX I LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
DODATEK I SEZNAM IMEN, FARMACEVTSKIH OBLIK, JAKOSTI ZDRAVILA, POTI UPORABE ZDRAVILA, IMETNIKOV DOVOLJENJ A ZA PROMET Z ZDRAVILOM V DRŽAVAH ČLANICAH
The Belanette blister is glued in a carton which is subsequently folded to a wallet configuration.
Pretisni omot zdravila Belanette je prilepljen na lepenko, ki je zložena v obliko, podobno denarnici.
• If this happens, you may be able to feel these pieces on your tongue.
• Če pride do tega, jih boste morda začutili na jeziku.
Date of first authorisation: 20 July 2011 Date of latest renewal: 18 February 2016
Datum prve odobritve: 20. julij 2011 Datum zadnjega podaljšanja: 18. februar 2016
Take the other 3 capsules in the same way.
Preostale 3 kapsule vzemite na enak način.
You then start another course.
Nato začnete z novim krogom.
Data in different age groups
Podatki v različnih starostnih skupinah
Taking your capsules at the same time each day will help you remember when to take them.
Če boste jemali kapsule vsak dan ob istem času, si boste lažje zapomnili, kdaj jih morate vzeti.
Some people do not get this infection until later on in their lives, while others get it very young.
Nekateri ljudje se okužijo šele v kasnejšem obdobju življenja, drugi pa že zelo mladi.
Tell your doctor if you have ever had any of the following conditions:
Posvetujte se z zdravnikom, če ste imeli kdaj prej katero od naslednjih težav:
It should appear pierced and empty.
Videti morate, da je predrta in prazna.
Cough was not related to bronchospasm.
Kašelj ni bil povezan z bronhospazmom.
People with cystic fibrosis have many symptoms of the disease.
Ljudje s cistično fibrozo imajo številne simptome te bolezni.
Elderly patients (≥65 years)
Starejši bolniki (stari 65 let ali več)
The dose is the same for everyone aged 6 years and older.
Odmerek je enak za vse bolnike, ki so stari 6 let ali več.
Patients after organ transplantation
Bolniki po presaditvi organa
• You are now ready to inhale the capsule in 2 separate breaths (Steps 8 and 9).
• Zdaj ste pripravljeni za inhaliranje vsebine kapsule z dvema ločenima vdihoma (koraka št. 8 in 9).
The frequencies in Table 1 are based on the reporting rates from the active-controlled study.
Pogostnosti v preglednici 1 temeljijo na pogostnosti poročil v aktivno kontrolirani študiji.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Pri zdravljenju je treba upoštevati uradne smernice o ustrezni uporabi antibakterijskih sredstev.
• Cough, productive cough, voice alteration (hoarseness)
• kašelj, produktiven kašelj, sprememba glasu (hripavost)
• Do not use this medicine after the expiry date which is stated on the box or capsule card.
• Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli ali tablici s kapsulami.
The hard capsules are supplied in PVC/PA/Alu/PVC- PET/Alu blisters.
Trde kapsule so na voljo v PVC/PA/Alu/PVC- PET/Alu pretisnih omotih.
• 7 capsule cards (one card for each day of the week).
• 7 tablic s kapsulami (ena tablica za vsak dan v tednu),
Use this if your weekly inhaler is not functioning correctly, is wet, or has dropped on the ground.
Uporabite ga v primeru, če inhalator iz tedenskega pakiranja ne deluje pravilno, je moker ali pade na tla.
Tell your doctor or a pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo, tudi če ste ga dobili brez recepta.
What is Pseudomonas aeruginosa
Kaj je Pseudomonas aeruginosa
In the active-controlled study, audiology testing was performed in selected centres accounting for about a quarter of the study population.
V aktivno kontrolirani študiji so preiskave sluha izvajali v izbranih študijskih centrih, opravila jih je približno četrtina bolnikov vključenih v študijo.
4 capsules = 1 dose
4 kapsule = 1 odmerek
Occasionally, very small pieces of the capsule can get past the screen and get into your mouth.
Občasno lahko zelo majhni delci kapsule zaidejo skozi mrežico v usta.
• Coughing up blood (very common)
• izkašljevanje krvi (zelo pogosto)
• Decreasing hearing (ringing in the ears is a potential warning sign of hearing loss), noises (such as hissing) in the ears (common).
• slabšanje sluha (zvenenje v ušesih je lahko opozorilni znak slabšanja sluha), zvoki (kot je sikanje) v ušesih (pogosti)
It is not known whether inhaling this medicine when you are pregnant causes side effects.
Ni znano, ali inhaliranje tega zdravila med nosečnostjo povzroča neželene učinke.
Keep it dry and store it in its case.
Pazite, da ostane suh, in ga shranjujte v etuiju.
Mylan IRE Healthcare Limited Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13 Ireland
Mylan IRE Healthcare Limited Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13 Irska
Basic instructions for use are given below, more detailed instructions are available from the patient leaflet.
Spodaj so podana osnovna navodila za uporabo, bolj podrobna navodila pa so na voljo v Navodilu za uporabo.
Otherwise, the patient should wait for the next dose and not inhale more capsules to make up for the missed dose.
V nasprotnem primeru mora bolnik počakati na naslednji odmerek in ne sme inhalirati več kapsul, da bi nadomestil izpuščeni odmerek.
FOUR capsules are required for ONE complete dose.
Za EN celoten odmerek potrebujete ŠTIRI kapsule.
Patients in this study had no exposure to inhaled tobramycin for at least 4 months prior to study start.
Bolniki v tej študiji najmanj 4 mesece pred začetkom študije niso bili izpostavljeni inhalacijskemu tobramicinu.
Monthly pack.
Mesečno pakiranje.
2 x monthly multipack wrapped in foil
2 x mesečno pakiranje, zavito v folijo
In the open label extensions, each additional 6 months of treatment resulted in incremental increases similar in magnitude to that observed in the 6 months of placebo-controlled studies.
V odprtih podaljšanjih študij je v vsakem dodatnem 6-mesečnem obdobju zdravljenja prišlo do zvišanja podobnega obsega kot v 6 mesecih v študijah, kontroliranih s placebom
See also information on clinical benefit and tolerability in sections 4.4, 4.8 and 5.1.
Glejte tudi podatke o kliničnih koristih in prenosljivosti v poglavjih 4.4, 4.8 in 5.1.
• muscle weakness that lasts or becomes worse over time, a symptom mostly related to conditions such as myasthenia or Parkinson's disease.
• šibkost mišic, ki vztraja ali se sčasoma še slabša, kar je večinoma simptom pri boleznih, kot sta miastenija ali Parkinsonova bolezen.
Your doctor will supervise your first dose of TOBI Podhaler and check your lung function before and after dosing.
Zdravnik bo nadzoroval vaše prvo odmerjanje zdravila TOBI Podhaler in preveril vašo pljučno funkcijo pred odmerjanjem zdravila in po njem.
• hearing problems (including noises in the ears and dizziness)
• težave s sluhom (vključno z različnimi zvoki v ušesih in z omotičnostjo),
ANNEX II A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
A. IZDELOVALEC, ODGOVOREN ZA SPROŠČANJE SERIJ B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA
224 capsules + 5 inhalers
224 kapsul + 5 inhalatorjev
The variability in pharmacokinetic parameters was higher in sputum as compared to serum.
Variabilnost farmakokinetičnih parametrov je bila večja v izpljunku kot v serumu.
Should cough remain unchanged, other antibiotics should be considered.
Če glede kašlja ne pride do sprememb, je treba razmisliti o uporabi drugih antibiotikov.
• blood in your sputum (the substance you cough up)
• kri v izpljunku (v vsebini, ki jo izkašljate),
These may still happen while taking TOBI Podhaler, but should not be any more frequent or seem worse than before.
Ti simptomi so lahko prisotni tudi v obdobju jemanja zdravila TOBI Podhaler, vendar ne bi smeli biti bolj pogosti ali bolj izraziti kot prej.
Tear the perforations along the length then width: see Figures (a) and (b).
Trgajte po perforaciji najprej po dolžini in nato po širini: glejte sliki (a) in (b).
Wash and fully dry your hands.
Roke si umijte in jih temeljito osušite.
If the infection is not properly fought, it will continue to damage your lungs, causing further problems to your breathing.
Če okužbe ne bi ustrezno zdravili, bi ta še naprej kvarila pljuča in tako povzročala nadaljnje težave z dihanjem.
The dose of TOBI Podhaler is the same for all patients within the approved age range, regardless of age or weight.
Odmerek zdravila TOBI Podhaler je v odobrenem starostnem okviru enak za vse bolnike, ne glede na starost ali telesno maso.
See also section 4.2.
Glejte tudi poglavje 4.2.
Your doctor may ask you to use other appropriate medicines before taking TOBI Podhaler.
Zdravnik vas bo morda prosil, da vzamete druga ustrezna zdravila pred uporabo zdravila TOBI Podhaler.
Unscrew mouthpiece (1) and remove the capsule from the chamber (2).
Odvijte ustnik (1) in vzemite kapsulo iz ležišča (2).
See also information on previous and concomitant use of systemic aminoglycosides and diuretics in section 4.4.
Glejte tudi podatke o predhodni in sočasni uporabi sistemskih aminoglikozidov in diuretikov v poglavju 4.4.
TOBI Podhaler should not be given to children less than 6 years old.
Zdravila TOBI Podhaler ne smejo prejemati otroci, ki so stari manj kot 6 let.
Do not use each inhaler and its case for longer than 1 week.
Posameznega inhalatorja z etuijem ne uporabljajte več kot 1 teden.
The Podhaler inhalation device and its storage case are made from plastic materials (polypropylene).
Inhalator Podhaler in njegov zaščitni etui sta izdelana iz plastičnih materialov (iz polipropilena).
Within each system organ class, the adverse drug reactions are ranked by frequency, with the most frequent reactions first.
V okviru vsakega organskega sistema so neželeni dogodki razvrščeni po pogostnosti, pri čemer so najprej navedeni najbolj pogosti učinki.
Haemoptysis is a complication in cystic fibrosis and is more frequent in adults.
Hemoptiza je zaplet pri cistični fibrozi in je bolj pogosta pri odraslih.
The main resistance mechanisms are drug efflux and drug inactivation by modifying enzymes.
Glavna mehanizma rezistence sta izločanje zdravila in inaktivacija zdravila z encimi, ki ga modificirajo.
The following medicines can increase the chances of harmful effects occurring if they are given to you while you are also receiving injections of tobramycin or other aminoglycoside antibiotic:
Naslednja zdravila lahko povečajo možnost, da pride do škodljivega delovanja, če jih prejemate v času, ko se zdravite tudi z injekcijami tobramicina ali drugih aminoglikozidnih antibiotikov:
Pharmacotherapeutic group: Antibacterials for systemic use, Aminoglycoside antibacterials, ATC Code: J01GB01
Farmakoterapevtska skupina: zdravila za sistemsko zdravljenje bakterijskih infekcij, aminoglikozidni antibiotiki, oznaka ATC: J01GB01
There are no adequate data on the use of tobramycin via inhalation in pregnant women.
Ni zadostnih podatkov o uporabi tobramicina z inhalacijo pri nosečnicah.
This analysis did not show gender or age-related pharmacokinetic differences
Pri tej analizi se ni pokazalo, da bi se farmakokinetične lastnosti razlikovale v odvisnosti od spola ali starosti.
If you are aged 65 years or older, your doctor may perform additional tests to decide if TOBI Podhaler is right for you.
Če ste stari 65 let ali več, bo zdravnik morda pri vas opravil dodatne preiskave, da bi ugotovil, ali je zdravilo TOBI Podhaler za vas primerno.
Aminoglycosides may aggravate muscle weakness because of a potential curare-like effect on neuromuscular function.
Aminoglikozidi lahko še dodatno poslabšajo šibkost mišic, saj lahko na živčno-mišično funkcijo delujejo podobno kot kurare.
Do not take the capsules out of the card in advance.
Kapsul ne jemljite iz tablice vnaprej.
• Look at the inhaler to make sure it is not damaged or dirty.
• Preglejte inhalator in se prepričajte, da ni poškodovan ali umazan.
Tobramycin is eliminated from the systemic circulation primarily by glomerular filtration of the unchanged compound.
Tobramicin se izloča iz sistemskega obtoka predvsem z glomerulno filtracijo nespremenjene spojine.
These medicines may cause muscle weakness to appear or become worse..
Navedena zdravila lahko povzročajo mišično šibkost ali njeno poslabšanje.
• The chances of the capsule breaking into pieces will be increased if the capsule is accidentally pierced more than once or if the device is not held with the mouthpiece pointing down during step 7.
• Možnost, da se kapsula tako zdrobi, je večja, če kapsulo pri koraku št. 7 nehote predrete več kot enkrat ali če inhalatorja pri tem ne držite z ustnikom navzdol.
Ask your pharmacist how to dispose of medicines and inhalers no longer required.
Pri farmacevtu se pozanimajte, kako lahko zavržete zdravila in inhalatorje, ki jih ne potrebujete več.